8 completed, 1 terminated, 1 withdrawn. 10 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 8, Terminated 1, Withdrawn 1 |
| Phase 3 | 1 | Completed 1 |
Follow Sleep Disorders: new trials by email Literature Review of Sleep Disorders trials Research Report on Sleep Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Verification of the Efficacy of NPC-15 for Sleep Disorders of Children With Autism Spectrum Disorders NPC-15 Granules Lower Dose, NPC-15 Granules Higher Dose, NPC-15 Placebo Granule - Sleep Disorders, Autism Spectrum Disorder | Phase 2 / Phase 3 | Completed | Nobelpharma | 196 | 2016-06-16 | 2019-04-16 |
| Does Melatonin Restore Sleep Architecture in Autistic Children melatonin, Melatonin, placebo - Sleep Disorders | Phase 2 | Completed | Hospices Civils de Lyon | 26 | 2014-06-01 | 2025-10-02 |
| Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction donepezil hydrochloride, Placebo - Anxiety Disorder, Breast Cancer | Phase 2 | Completed | Wake Forest University Health Sciences | 62 | 2012-07-01 | 2021-10-20 |
| Home-Based Programs for Improving Sleep in Cancer Survivors Home-based sleep intervention - Cancer Survivor, Fatigue | Phase 2 | Terminated | Alliance for Clinical Trials in Oncology | 93 | 2010-04-01 | 2019-12-03 |
| Exploratory Subjective Sleep Study of a Prototype Nasal Dilator Prototype Nasal Dilator, Marketed Nasal Strip, Placebo Nasal Strip - Sleep Disorders, Congestion, Nasal | Phase 2 | Completed | GlaxoSmithKline | 61 | 2009-10-01 | 2018-04-09 |
| Vestipitant 28-day Tolerance Study GW597599, Placebo - Sleep Disorders | Phase 2 | Completed | GlaxoSmithKline | 161 | 2009-05-01 | 2016-10-28 |
| Melatonin Supplementation to Improve Sleep in Patients With Heart Failure melatonin, placebo - Heart Failure, Sleep Disorders | Phase 2 | Withdrawn | Brigham and Women's Hospital | 2009-03-01 | 2018-01-19 | |
| Yoga in Treating Sleep Disturbance in Cancer Survivors Standard Care Control Condition, Yoga Intervention (YOCAS) - Fatigue, Cancer | Phase 2 | Completed | Gary Morrow | 410 | 2006-10-01 | 2017-02-20 |
| Exercise Training in Dialysis Patients With Restless Legs Syndrome (RLS) Dopamine Agonist and Exercise - Restless Legs Syndrome, End Stage Renal Disease | Phase 2 | Completed | University of Thessaly | 46 | 2006-09-01 | 2010-07-05 |
| Melatonin Supplements for Improving Sleep in Individuals With Hypertension Melatonin, Placebo - Sleep Disorders, Hypertension | Phase 2 | Completed | Brigham and Women's Hospital | 16 | 2005-10-01 | 2017-11-14 |
Sleep Wake Disorders (10) · Fatigue (3) · Anxiety Disorders (1) · Autism Spectrum Disorder (1) · Breast Neoplasms (1) · Cardiovascular Diseases (1) · Cognition Disorders (1) · Depression (1) · Heart Failure (1) · Hypertension (1) · Kidney Failure, Chronic (1) · Mental Disorders (1) · Motor Activity (1) · Nasal Obstruction (1) · Neoplasms (1)
Pathological Conditions, Signs and Symptoms (10) · Mental Disorders (9) · Nervous System Diseases (9) · Neurologic Manifestations (9) · Signs and Symptoms (9) · Behavior (2) · Dyssomnias (2) · Sleep Disorders, Intrinsic (2) · Airway Obstruction (1) · Behavioral Symptoms (1) · Breast Diseases (1) · Cardiovascular Diseases (1) · Child Development Disorders, Pervasive (1) · Chronic Disease (1) · Disease Attributes (1)
Melatonin (4) · Donepezil (1) · Dopamine Agonists (1) · Exercise (1) · vestipitant (1)
Brigham and Women's Hospital (2) · GlaxoSmithKline (2) · Alliance for Clinical Trials in Oncology (1) · Gary Morrow (1) · Hospices Civils de Lyon (1) · Nobelpharma (1) · University of Thessaly (1) · Wake Forest University Health Sciences (1)
United States (5) · France (1) · Germany (1) · Greece (1)
Debra Barton, RN, PhD, AOCN, FAAN (1) · Frank AJ Scheer, PhD (1) · Giorgos K Sakkas, PhD (1) · Ioannis Stefanidis, MD PhD (1) · Julia A. Lawrence (1) · Karen M. Mustian, PhD (1) · Patricia Franco, MD (1) · Yushiro Yamashita, MD, PhD (1)
PMID 23024438, PMID 23929523, PMID 23940231, PMID 24024727, PMID 26262586, PMID 30154874, PMID 31165647, PMID 32307658, PMID 32912180, PMID 35018639, PMID 39368335, PMID 40421669
R21AT002713 (1), U10CA037420 (1), U10CA081851 (1)